LR 19020
Alternative Names: LR-19020Latest Information Update: 06 Jun 2024
At a glance
- Originator LG Chem
- Class Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Obesity
Most Recent Events
- 12 Apr 2024 LR 19020 is available for licensing as of 12 Apr 2024. https://innovation.lgchem.com/ResearchDevelopment/Partnership.do
- 12 Apr 2024 Preclinical trials in Obesity in South Korea (unspecified route) (LG Chem Pipeline, April 2024)